ORA-SED JEL
General Sale List
Drug type: Therapeutic
ATC code: A01AD11
Dosage form: GEL
Route of administration: ORAL
Active ingredient: BENZALKONIUM CHLORIDE; CHOLINE SALICYLATE; BENZALKONIUM CHLORIDE; CHOLINE SALICYLATE
Indication: Transient mouth ulcers, denture discomfort, infant teething pain, sore gums.
Contraindications: Not to be used in infants where viral infection is suspected.
Warnings/reminders/instructions to users: This product should not be given to patients known to be hypersensitive to salicylate.
Suggested dose, dosage regimen and method of application:
For infants above 4 months apply Ora-Sed Jel every three hours at bedtime. Massage well into gums. For the treatment of mouth ulcers wipe surface free of mucus before application.
Avoid prolonged treatment in infants.
Registrant
INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED
Approval Date
1990-07-16
Approval Number
SIN04948P
Manufacturer
HAMILTON PHARMACEUTICAL PTY LTD
Licence Holder
INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED